"Pharmacogenetics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION).
Descriptor ID |
D010597
|
MeSH Number(s) |
H01.158.273.343.750 H01.158.703.052 H02.628.479
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pharmacogenetics".
Below are MeSH descriptors whose meaning is more specific than "Pharmacogenetics".
This graph shows the total number of publications written about "Pharmacogenetics" by people in this website by year, and whether "Pharmacogenetics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 5 | 6 |
2004 | 4 | 6 | 10 |
2005 | 6 | 7 | 13 |
2006 | 1 | 4 | 5 |
2007 | 3 | 6 | 9 |
2008 | 1 | 3 | 4 |
2009 | 4 | 9 | 13 |
2010 | 1 | 8 | 9 |
2011 | 1 | 9 | 10 |
2012 | 3 | 9 | 12 |
2013 | 2 | 5 | 7 |
2014 | 2 | 6 | 8 |
2015 | 5 | 6 | 11 |
2016 | 4 | 2 | 6 |
2017 | 3 | 8 | 11 |
2018 | 4 | 3 | 7 |
2019 | 2 | 3 | 5 |
2020 | 5 | 5 | 10 |
2021 | 1 | 1 | 2 |
2022 | 4 | 2 | 6 |
2023 | 4 | 1 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pharmacogenetics" by people in Profiles.
-
Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub-Saharan African Populations. Clin Pharmacol Ther. 2024 Mar; 115(3):576-594.
-
Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child? Genet Med. 2024 Feb; 26(2):101033.
-
A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-na?ve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms. Neuropsychopharmacology. 2024 Apr; 49(5):893-902.
-
Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice. Psychiatry Res. 2023 07; 325:115246.
-
An efficient genotyper and star-allele caller for pharmacogenomics. Genome Res. 2023 01; 33(1):61-70.
-
Characterization of CYP2D6 Pharmacogenetic Variation in Sub-Saharan African Populations. Clin Pharmacol Ther. 2023 03; 113(3):643-659.
-
Five Priorities of African Genomics Research: The Next Frontier. Annu Rev Genomics Hum Genet. 2022 08 31; 23:499-521.
-
Whole-genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program. Genome Med. 2022 03 28; 14(1):34.
-
Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study. Genet Med. 2022 05; 24(5):1062-1072.
-
Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing? J Mol Diagn. 2022 03; 24(3):253-261.